Problem of managing patients with epilepsy in developing countries.
Kuruvilla
A
A
D000927:Anticonvulsants / Q000191:economics / Q000627:therapeutic use*; D002220:Carbamazepine / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D004827:Epilepsy / Q000145:classification / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007194:India; D010672:Phenytoin / Q000191:economics / Q000627:therapeutic use; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome; D014481:United States
D000927:Anticonvulsants; D002220:Carbamazepine; D010672:Phenytoin